Literature DB >> 10789503

The complete DNA sequence of the O antigen gene region of Plesiomonas shigelloides serotype O17 which is identical to Shigella sonnei form I antigen.

T Chida1, N Okamura, K Ohtani, Y Yoshida, E Arakawa, H Watanabe.   

Abstract

We cloned and determined the sequence of a DNA region of approximately 15-kb containing the cluster of genes required for O17 antigen expression in the Escherichia coli K-12 strain from the chromosome of Plesiomonas shigelloides serotype O17:H2 strain. The sequencing analysis revealed that the minimum essential region of the P. shigelloides O17 antigen gene cluster had a size of approximately 11.5-kb and contained 9 contiguous open reading frames (ORFs), which were almost identical to the corresponding ORFs of Shigella sonnei form I antigen gene region, except for IS630 sequence, at the DNA as well as amino acid levels. The putative function of most of the ORFs could be determined on the basis of amino acid sequence similarities and characteristics. In addition, the G+C content of the P. shigelloides O17 antigen genes was lower than that of the chromosomal DNA of P. shigelloides and S. sonnei, suggesting that both P. shigelloides O17 and S. sonnei form I antigen genes had been derived from the same origin with a low G+C content.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10789503     DOI: 10.1111/j.1348-0421.2000.tb02478.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  2 in total

1.  Polysaccharide biosynthesis locus required for virulence of Bacteroides fragilis.

Authors:  M J Coyne; A O Tzianabos; B C Mallory; V J Carey; D L Kasper; L E Comstock
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

2.  Molecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live salmonella vaccine vector.

Authors:  De-Qi Xu; John O Cisar; Nicholas Ambulos; Donald H Burr; Dennis J Kopecko
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.